Dogwood Therapeutics, Inc.

NASDAQ:DWTX

Biotechnology

Healthcare
$1.52 +2.22%

+$0.04 today

Market cap
$51.12M
Beta
1.76
P/E (TTM)
-0.2
EPS (TTM)
-$0.84
52W Low $1.28High $9.50

Volume 0.12M

Average 0.09M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$27.97M

FY 2025 · Annual

Net Income

-$34.26M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development10.8M8.07M1.73M3.53M21.87M
Selling, General & Admin4.85M4.25M3.72M8.7M6.1M
Operating Expenses15.64M12.32M5.45M12.23M27.97M
Depreciation & Amortization00012.18K2.06K
EBITDA(15.96M)(12.25M)(5.3M)(12.25M)(34.03M)
EBITDA Margin—————
Operating Income(15.64M)(12.32M)(5.45M)(12.23M)(27.97M)
Operating Margin—————
Interest Income5.67K67.48K150.9K096.94K
Interest Expense00092.19K0
Other Income / Expenses(319.33K)67.48K150.9K(122.98K)(6.07M)
Income Before Tax(15.96M)(12.25M)(5.3M)(12.35M)(34.04M)
Pre-Tax Margin—————
Income Tax Expense000(503)221.1K
Net Income(15.96M)(12.25M)(5.3M)(12.35M)(34.26M)
Net Margin—————
EPS (Basic)(47.90)(27.66)(7.05)(12.52)(4.32)
EPS (Diluted)(47.90)(27.66)(7.05)(12.52)(4.32)
Weighted Avg Shares333.17K442.8K751.07K1.03M8.22M
Weighted Avg Shares (Diluted)333.17K442.8K751.07K1.03M8.22M

DWTX Earnings Waterfall · TTM

NASDAQ:DWTX · Revenue to Net Income

Key Ratios

EPS$-10.60
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-2.1
P/S Ratio0.0

Analysis

$0 of revenue converted into -$28.3M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-10.60, tying the income statement back to per-share earnings.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 7, 2025
8-KCurrent reportNov 6, 2025
DEF 14ADEF 14A filingOct 20, 2025
S-3/AS-3/A filingOct 16, 2025
DEFA14ADEFA14A filingOct 9, 2025

How much revenue does DWTX generate?

Dogwood Therapeutics, Inc. (DWTX) reported $0.00 of revenue in fiscal 2025.

Is DWTX profitable?

Dogwood Therapeutics, Inc. (DWTX) reported -$34.26M of net income.